RUSSO, Claudio
 Distribuzione geografica
Continente #
NA - Nord America 2.650
EU - Europa 2.163
AS - Asia 297
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 10
SA - Sud America 8
OC - Oceania 7
Totale 5.237
Nazione #
US - Stati Uniti d'America 2.629
IE - Irlanda 709
IT - Italia 276
UA - Ucraina 206
FI - Finlandia 172
SE - Svezia 167
RU - Federazione Russa 148
CN - Cina 132
AT - Austria 126
DE - Germania 119
GB - Regno Unito 107
CI - Costa d'Avorio 98
SG - Singapore 93
BE - Belgio 50
FR - Francia 21
CZ - Repubblica Ceca 20
IN - India 19
VN - Vietnam 18
CA - Canada 17
EU - Europa 10
NL - Olanda 9
ES - Italia 7
IR - Iran 7
CO - Colombia 6
JP - Giappone 5
LT - Lituania 5
NZ - Nuova Zelanda 4
AU - Australia 3
EE - Estonia 3
KR - Corea 3
LV - Lettonia 3
MA - Marocco 3
MY - Malesia 3
RO - Romania 3
BG - Bulgaria 2
IL - Israele 2
LK - Sri Lanka 2
MD - Moldavia 2
MX - Messico 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LU - Lussemburgo 1
PA - Panama 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 5.237
Città #
Dublin 709
Jacksonville 517
Chandler 474
Wilmington 166
Ann Arbor 143
Vienna 126
San Mateo 120
Helsinki 113
Houston 113
Abidjan 98
Woodbridge 94
Boardman 84
Dearborn 79
Princeton 68
Molise 65
Beijing 51
Brussels 50
Singapore 48
Los Angeles 41
Ashburn 39
New York 30
Rome 24
Naples 17
Dong Ket 16
Spoltore 16
Redwood City 13
Augusta 11
Hefei 10
Jinan 10
Milan 9
Moscow 9
Dallas 8
Leawood 8
Shenyang 8
Toronto 7
Auburn Hills 6
Hebei 6
Mountain View 6
Bogotá 5
Civitanova Marche 5
Nanchang 5
Napoli 5
Amsterdam 4
Ardabil 4
Frankfurt am Main 4
Guangzhou 4
Kunming 4
London 4
Nanjing 4
Zhengzhou 4
Auckland 3
Caserta 3
Centro 3
Falkenstein 3
Forio 3
Genova 3
Monmouth Junction 3
Norwalk 3
Ottawa 3
Pescara 3
Philadelphia 3
Riga 3
Rockville 3
San Giovanni Rotondo 3
Tallinn 3
Udine 3
Wuhan 3
Bangalore 2
Bengaluru 2
Borås 2
Bratislava 2
Campobasso 2
Campoformido 2
Cassino 2
Changsha 2
Chisinau 2
Colombo 2
Isernia 2
Islamabad 2
Kuala Lumpur 2
Lappeenranta 2
Melbourne 2
Mumbai 2
Newark 2
Noicattaro 2
Paris 2
Phoenix 2
Prague 2
Saint-Fons 2
Salerno 2
San Francisco 2
Seattle 2
Sofia 2
Tappahannock 2
Turin 2
Viterbo 2
West Hartford 2
West Jordan 2
Afragola 1
Aguascalientes 1
Totale 3.579
Nome #
Activation and Desensitization of Trpv1 Channels in Sensory Neurons by the Peroxisome Proliferator-Activated Receptor α Agonist Palmitoylethanolamide 152
Analysis of protease levels in brain samples from Alzheimer’s patients 145
METODO PER RILEVARE LA PRESENZA E LA QUANTITA DEL RECETTORE LRP8 E DEI SUOI FRAMMENTI PROTEOLITICI, KIT DI RILEVAMENTO E RELATIVI ANTICORPI 145
Complexity and Selectivity of γ -Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer 135
Serum levels of acyl-carnitines along the continuum from normal to Alzheimer's dementia 132
Magnetic Resonance Imaging correlates of benign and malignant alterations of the spinal bone marrow 112
Levels of acyl-carnitines in serum of patient with or at risk of Alzheimer’s disease. 111
Proteases Upregulation in Sporadic Alzheimer's Disease Brain 110
Pharmacological activation of autophagy favors the clearing of intracellular aggregates of misfolded prion protein peptide to prevent neuronal death 101
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease 97
The "Alzheimer's disease signature": potential perspectives for novel biomarkers 91
Pyroglutamate-modified amyloid β-peptides - aβN3(pE) - strongly affect cultured neuron and astrocyte survival 89
Alzheimer's disease: Molecular consequences of presenilin-1 mutation 89
Adiponectin as novel regulator of cell proliferation in human glioblastoma 88
Imaging of metabolic bone disease 87
Amyloid-beta Protein Precursor Regulates Phosphorylation and Cellular Compartmentalization of Microtubule Associated Protein Tau 86
The β-amyloid precursor protein APP is tyrosine phosphorilated in cells expressing a constitutively active form of the Abl protoncogene 85
N-Terminally truncated amyloid b peptides and Alzheimer's disease 82
BACE-2 is overexpressed in Down's syndrome 81
Persistent increase of d-aspartate in d-aspartate oxidase mutant mice induces a precocious hippocampal age-dependent synaptic plasticity and spatial memory decay 81
Presenilin1 modulation of amyloid precursor protein processing: occurrence and relevance of N-truncated β-amyloid and carboxy-terminal fragments in AD pathology 81
Enhancement of Glycine release from human brain cortex by acetylcholine acting at M4 muscarinic receptors 81
The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications 80
Bace overexpression regulates amyloid precursor protein cleavage and interaction with ShcA adapter 79
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 78
NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion 78
Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling 77
Presence of soluble amyloid b peptide precedes amyloid plaque formation in Down’s syndrome 77
Apoptotic cell death influences the signaling activity of the Amyloid Precursor Protein through ShcA and Grb2 adaptor proteins in neuroblastoma SH-SY5Y cells 77
a-Glycerylphosphorylethanolamine rescues astrocytes from mitochondrial impairment and oxidative stress induced by amyloid b-peptides 76
Farmaci nella terapia della demenza di Alzheimer 76
Selection of Candidate Housekeeping Genes for Normalization in Human Postmortem Brain Samples 76
Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain 74
Amino-terminally truncated prion protein PrP90-231 induces microglial activation in vitro 74
Opposite roles of apolipoprotein E in normal brains and in Alzheimer’s disease 74
Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid β-peptides induced oxidative stress and reduces NF-kB activation 73
Presenilin-1 mutations in Alzheimer's disease 73
Molecular aspects of neurodegeneration in Alzheimer’s disease 71
Human brain amyloidoses 70
An intronic ncRNA-dependent regulation of SORL1 expression affecting Aβ formation is upregulated in post-mortem Alzheimer's disease brain samples 69
Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain 69
A novel snRNA-like transcript affects amyloidogenesis and cell cycle progression through perturbation of Fe65L1 (APBB2) alternative splicing. 67
Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid β-protein precursor 66
Amyloid precursor protein modulates ERK1/2 signaling 65
Functional and biochemical interaction between PPARα receptors and TRPV1 channels: Potential role in PPARα agonists-mediated analgesia. 65
Amyloid precursor protein and Presenilin 1 interaction studied by FRET in human H4 cells 63
Mechanisms of phenotypic heterogeneity in prion, Alzheimer and other conformational diseases 63
Apoptotic cell death and Amyloid Precursor Protein signaling in neuroblastoma SH-SY5Y cells 63
Cutaneous Ulcer Caused by Apixaban Treatment Is Resolved after Replacement with Dabigatran 62
Efficacy of Novel Acridine Derivatives in the Inhibition of hPrP90-231 Prion Protein Fragment Toxicity 62
RNA polymerase III drives alternative splicing of the potassium channel-interacting protein contributing to brain complexity and neurodegeneration 62
Dual modulation of ERK1/2 and p38 MAP kinase activities induced by minocycline reverses the neurotoxic effects of the prion protein fragment 90-231 61
Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling 61
Amyloid precursor protein and presenilin involvement in cell signaling 61
Different structural stability and toxicity of PrP(ARR) and PrP(ARQ) sheep prion protein variants 57
Identification of amino-terminally and phosphotyrosine modified carboxy-terminal fragments of the amyloid precursor protein in Alzheimer’s disease and Down’s syndrome brain 57
Conformation dependent pro-apoptotic activity of the recombinant human prion protein fragment 90-231 57
ERK1/2 and p38 MAP kinases control prion protein fragment 90-231-induced astrocyte proliferation and microglia activation 56
Intracellular accumulation of a mild-denatured monomer of the human PrP fragment 90-231, as possible mechanism of its neurotoxic effects 56
Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein 54
Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain 53
Heterogeneity of water-soluble amyloid b-peptide in Alzheimer’s disease and Down’s syndrome 53
Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic 52
Beta amyloid is different in normal aging and in Alzheimer's disease 47
Characterization of the proapoptotic intracellular mechanisms induced by a toxic conformer of the recombinant human prion protein fragment 90-231 47
Bidirectional Control between Cholesterol Shuttle and Purine Signal at the Central Nervous System 43
The inhibition of 45A ncRNA expression reduces tumor formation, affecting tumor nodules compactness and metastatic potential in neuroblastoma cells 43
Severe hypotension, bradycardia and asystole after sugammadex administration in an elderly patient 42
Sudden cardiac death caused by a fatal association of hypertrophic cardiomyopathy (Myh7, p.arg719trp), heterozygous familial hypercholesterolemia (ldlr, p.gly343lys) and sars-cov-2 b.1.1.7 infection 40
Reply to Sagliocco, O.; Betelli, M. Comment on “Fierro et al. Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient. Medicina 2021, 57, 79” 38
Innovative Phospholipid Carriers: A Viable Strategy to Counteract Antimicrobial Resistance 16
αS1-Casein-Loaded Proteo-liposomes as Potential Inhibitors in Amyloid Fibrillogenesis: In Vivo Effects on a C. elegans Model of Alzheimer’s Disease 2
Totale 5.316
Categoria #
all - tutte 26.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.076


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020512 0 0 0 0 70 49 148 38 83 41 10 73
2020/2021658 9 65 2 91 90 49 73 2 80 12 134 51
2021/2022410 41 95 13 40 27 26 9 30 72 20 11 26
2022/20231.869 201 67 27 186 134 161 1 78 873 70 36 35
2023/2024328 60 41 16 7 29 47 10 35 5 24 3 51
2024/2025528 118 36 184 14 176 0 0 0 0 0 0 0
Totale 5.316